Protara Therapeutics, Inc. (TARA)
$2.62-5.42%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $147M
- Beta
- 1.47
- P/E (TTM)
- -1.93
- Short % float
- 11.78%
- Days to cover
- 2.9
- SI change
- +31.1%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TARA?
- LOPJLB’s latest quantitative signal on Protara Therapeutics, Inc. (TARA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TARA in?
- Protara Therapeutics, Inc. (TARA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Protara Therapeutics, Inc. (TARA) do?
- Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation f…